Skip to main content
Clinical Trials/TCTR20240817007
TCTR20240817007
Completed
Phase 3

Effect of Oral Sodium Bicarbonate Supplementation on urine TGF-beta in normal serum bicarbonate CKD, A randomized control trial.

Department of Medicine, Phramongkutklao Hospital and College of Medicine0 sites64 target enrollmentAugust 17, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
on-diabetic chronic kidney disease with subclinical metabolic acidosis
Sponsor
Department of Medicine, Phramongkutklao Hospital and College of Medicine
Enrollment
64
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 17, 2024
End Date
February 21, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Medicine, Phramongkutklao Hospital and College of Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\.Age \> 18 years old
  • 2\.Non\-diabetic CKD stage 3\-4
  • 3\.Normal serum bicarbonate
  • (HCO3 22\-26 mEq/L)

Exclusion Criteria

  • 1\.Use of chronic daily oral alkali (such as sodium bicarbonate, sodium citrate, potassium citrate, etc)
  • 2\.Serum potassium \< 3\.3 or \> 5\.5 mEq/L
  • 3\.Self\-reported vegetarian
  • 4\.New York Heart Association Class 3 or 4 heart failure symptom
  • 5\.History of staghorn calculi
  • 6\.Active glomerular disease requiring immunosuppressive agents
  • 7\.Kidney transplant patient
  • 8\.Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials